Role of prophylactic bilateral tonsillectomy as a cancer preventive strategy

Cancer Prevention Research

Volumn 8, Issue 7, 2015, Pages 580-582

  Misiukiewicz, Krzysztof ^a   Posner, Marshall ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; EDITORIAL; HEALTH CARE COST; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; PROPHYLACTIC SURGICAL PROCEDURE; TONSIL CARCINOMA; TONSILLECTOMY; VACCINATION; FEMALE; MALE; OROPHARYNGEAL NEOPLASMS;

FEMALE; HUMANS; MALE; OROPHARYNGEAL NEOPLASMS; TONSILLECTOMY;

EID: 84942433328     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-15-0153     Document Type: Editorial

References (22)

1. Sturgis EM, Ang KK. The epidemic of HPV-associated oropharyngeal cancer is here: is it time to change. J Natl Compr Canc Netw 2011;9:665-73.
2. CDC, Human papillomavirus-associated cancers - United States, 2004-2008. MMWR 2012;61:258-261.
3. Kreimer AR, Chaturvedi AK. HPV-associated oropharyngeal cancers - are they preventable? Cancer Prev Res 2011;4:1346-9.
4. Fakhry C, Rosenthal BT, Clark DP, Gillison ML. Associations between oral HPV16 infection and cytopathology: evaluation of an oropharyngeal "paptest equivalent" in high-risk populations. Cancer Prev Res 2011;4:1378-84.
5. Palmer E, Newcombe RG, Green AC, Kelly C, Noel Gill O, Hall G, et al. Human papillomavirus infection is rare in nonmalignant tonsil tissue in the UK. Int J Cancer 2014;135:2437-43.
6. Nankivell P, Williams H, Webster K, Pearson D, High A, MacLennan K, et al. Investigation of p16(INK4a) as a prognostic biomarker in oral epithelial. J Oral Pathol Med 2014;43:245-9.
7. Fakhry C, Andersen KK, Christensen J, Agrawal N, Eisele DW. The impact of tonsillectomy upon the risk of oropharyngeal carcinoma diagnosis and prognosis in the Danish Cancer Registry. Cancer Prev Res 2015;8:583-89.
8. Erickson BK, Larson DR, St Sauver JL, Meverden RA, Orvidas LJ. Changes in incidence and indications of tonsillectomy and adenotonsillectomy. Otolaryngol Head Neck Surg 2009;140:894-901.
9. Seshamani M, Vogtmann E, Gatwood J, Gibson TB, Scanlon D. Prevalence of complications from adult tonsillectomy and impact on health care. Otolaryngol Head Neck Surg 2014;150:574-81.
10. Brasky TM, Bonner MR, Dorn J, Marhsall JR, Vena JE, Brasure JR, et al. Tonsillectomy and breast cancer risk in the Western New York Diet Study. Cancer Causes Control 2009;20:369-74.
11. Joseph AW, Ogawa T, Bishop JA, Lyford-Pike S, Chang X, Phelps TH, et al. Molecular etiology of second primary tumors in contralateral tonsils of human. Oral Oncol 2013;49:244-8.
12. Haddad R, Crum C, Chen Z, Krane J, Posner M, Li Y, et al. HPV16 transmission between a couple with HPV-related head and neck cancer. Oral Oncol 2008;44:812-5.
13. D'Souza G, Gross ND, Pai SI, Haddad R, Anderson KS, Rajan S, et al. Oral human papillomavirus (HPV) infection in HPV-positive patients with oropharyngeal cancer and their partners. J Clin Oncol 2014;32:2408-15.
14. Mork J, Lie AK, Glattre E, Hallmans G, Jellum E, Koskela P, et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001;344:1125-31.
15. Kreimer AR, Johansson M, Waterboer T, Kaaks R, Chang-Claude J, Drogen D, et al. Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer. J Clin Oncol 2013;31:2708-15.
16. Carvalho AL, Jeronimo C, Kim MM, Henrique R, Zhang Z, Hoque MO, et al. Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma. Clin Cancer Res 2008;14:97-107.
17. Nunes DN, Kowalski LP, Simpson AJ. Detection of oral and oropharyngeal cancer by microsatellite analysis in mouth. Oral Oncol 2000;36:525-8.
18. Wadsworth JT, Somers KD, Stack BC Jr, Cazares L, Malik G, Adam BL, et al. Identification of patients with head and neck cancer using serum protein. Arch Otolaryngol Head Neck Surg 2004;130:98-104.
19. CDC. Licensure of Bivalent Human Papillomavirus Vaccine (HPV2, Cervarix) for Use in Females and Updated HPV Vaccination Recommendations from the Advisory Committee on Immunization Practices (ACIP) Weekly May 28, 2010/59-20; 626-9. 2010.
20. CDC, National and state vaccination coverage among adolescents aged 13-17 years - United States, 2012.
21. European Centre for Disease Prevention and Control. Introduction of HPV vaccines in EU countries - an update. Stockholm: ECDC; 2012.
22. Gillison ML, Broutian T, Pickard RK, Tong ZY, Xiao W, Kahle L, et al. Prevalence of oral HPV infection in the United States, 2009-2010. JAMA 2012;307:693-703.